1. Home /
  2. Science

Science

Apollo 11: Test Your Memory With TheStreet Trivia

Apollo 11: Test Your Memory With TheStreet Trivia

Test your memory with TheStreet trivia. How well do you remember the original Apollo 11 launch?

Sarepta Therapeutics Looks Ready to Break Out to the Upside

Sarepta Therapeutics Looks Ready to Break Out to the Upside

Here's how to play this stock.

Edwards Lifesciences Has Formula for Long-Lasting Rally

Edwards Lifesciences Has Formula for Long-Lasting Rally

EW has had some corrections and pullbacks along the way during this long and strong rally from $80 to nearly $200, but its price target is $240.

How to Profit as Plant-Based Meat Takes Off

How to Profit as Plant-Based Meat Takes Off

Look further down the literal food chain than Beyond Meat and Impossible Burger. And also, here's one stock to potentially avoid.

What Is Full-Spectrum CBD?

What Is Full-Spectrum CBD?

Full-spectrum CBD takes a team approach to tackling various physical and emotional health issues. Does it work?

What Is Business Intelligence?

What Is Business Intelligence?

Business Intelligence software collects, stores and analyzes data, turning it into useful information to help businesses make better decisions.

CBD Oil vs. Hemp Oil: What's the Difference in 2019?

CBD Oil vs. Hemp Oil: What's the Difference in 2019?

CBD oil and hemp oil have different scientific elements, but both claim to fight common ailments that are giving the oils a growing fan base.

What is the Impact on Investors of DowDuPont's Reverse Stock Split?

What is the Impact on Investors of DowDuPont's Reverse Stock Split?

Following the April 2nd spinoff of Dow, DowDuPont announced a reverse stock split. ActionAlertsPLUS Research Analyst Zev Fima explains what that means both institutional and retail investors.

What Does the DowDuPont Spinoff Mean for Investors?

What Does the DowDuPont Spinoff Mean for Investors?

On April 2nd, 2019 Dow Inc. spun off of DowDuPont and replaced it in the Dow Jones Industrial Average. ActionAlertsPLUS Senior Portfolio Analyst Jeff Marks explains what it means for investors.

Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now

Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now

With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.